DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Astrazeneca


AstraZeneca Covid Vaccine Shows 70% Efficacy

24.11.2020 -

AstraZeneca’s viral vector vaccine candidate for Covid-19, AZD1222, moved back into the spotlight again this week after giving up headlines recently to the mRNA...


Samsung Super Plant to Supply AstraZeneca

12.10.2020 -

Korean CMO Samsung Biologics has signed on with AstraZeneca to support the UK drugmaker’s biologics therapeutics. The company will produce bulk drug substance and drug...


AstraZeneca US Vaccine Trial in Limbo

16.09.2020 -

The US Food and Drug Administration (FDA) is deliberating whether to allow AstraZeneca to resume its recently begun Phase 3 US clinical trial of the adenovirus-based...


AstraZeneca Resumes UK Covid Vaccine Trials

14.09.2020 -

AstraZeneca has resumed Phase 2/3 clinical trials with Oxford University’s Covid-19 vaccine candidate in the UK, days after halting the tests due to an “adverse...


Vaccine Makers Pledge Caution on Covid Rollout

09.09.2020 -

With some potential Covid-19 vaccine makers suggesting they could have a candidate ready for approval and maybe even deployment this autumn, concerns are arising that a...


EU Seals AZ Vaccine Deal, Makes Strides on Others

28.08.2020 -

After months of uncertainty and anxious glances across the water as potential Covid-19 vaccine manufacturers made deal after deal with other political blocs, the EU over...


Catalent in new Vaccine Production Deal with AstraZeneca

27.08.2020 -

Catalent Cell & Gene Therapy, a unit of US-based CDMO Catalent, has signed on to provide drug substance manufacturing to AstraZeneca for the University of Oxford’s...


Australia Inks Vaccine Deal with AstraZeneca

21.08.2020 -

The government of Australia has sealed a deal with AstraZeneca to supply enough doses of the adenovirus vector-based vaccine being developed on behalf of Oxford...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.